Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition

Free Radical Biology and Medicine

Volumn 76, Issue , 2014, Pages 1-13

  Prasanphanich, Adam F ^a   Arencibia, C Andrew ^a   Kemp, Melissa L ^a  

^a Emory University   (United States)

Author keywords

Epithelial mesenchymal transition; In cell; Multivariate analysis; Multivariate phenotype; Nucleophilic tone; Principal component analysis; Transdifferentiation; Transforming growth factor ; Western assay

Indexed keywords

GLUTATHIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; HYDROGEN PEROXIDE; LUMINOL; NOX4 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMAD2 PROTEIN, HUMAN; SMAD4 PROTEIN, HUMAN;

ARTICLE; CELL TRANSDIFFERENTIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; OXIDATION; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PHENOTYPE; POSITIVE FEEDBACK; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; DRUG EFFECTS; FLUORESCENCE; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL TRANSDIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENCE; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; LUMINOL; LUNG NEOPLASMS; NADPH OXIDASE; OXIDATION-REDUCTION; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84907160367     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.07.032     Document Type: Article

References (83)

1. C.H. Waddington Canalization of development and the inheritance of acquired characters Nature 150 1942 563 565
2. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Invest. 119 2009 1420 1428
3. J.P. Thiery, H. Acloque, R.Y.J. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
4. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
5. M. Oft, K.H. Heider, and H. Beug TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis Curr. Biol. 8 1998 1243 1252
6. B. Bierie, and H.L. Moses Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer Nat. Rev. Cancer 6 2006 506 520
7. D.J. Junk, R. Cipriano, B.L. Bryson, H.L. Gilmore, and M.W. Jackson Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events Neoplasia 15 2013 1100 1109
8. M. Yu, A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, and S. Maheswaran Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Science 339 2013 580 584
9. H. Hugo, M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams, and E.W. Thompson Epithelial - mesenchymal and mesenchymal - epithelial transitions in carcinoma progression J. Cell Physiol. 213 2007 374 383
10. R.Y.-J. Huang, M.K. Wong, T.Z. Tan, K.T. Kuay, A.H.C. Ng, V.Y. Chung, Y.-S. Chu, N. Matsumura, H.-C. Lai, Y.F. Lee, W.-J. Sim, C. Chai, E. Pietschmann, S. Mori, J.J.H. Low, M. Choolani, and J.P. Thiery An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530) Nature 4 2013 e915 13
11. F. Liu, C. Pouponnot, and J. Massagué Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta -inducible transcriptional complexes Genes Dev. 11 1997 3157 3167
12. S. Souchelnytskyi Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling J. Biol. Chem. 272 1997 28107 28115
13. Y. Katsuno, S. Lamouille, and R. Derynck TGF-β signaling and epithelial-mesenchymal transition in cancer progression Curr. Opin. Oncol. 25 2013 76 84
14. J. Dzwonek, O. Preobrazhenska, S. Cazzola, A. Conidi, A. Schellens, M. van Dinther, A. Stubbs, A. Klippel, D. Huylebroeck, P. Dijke ten, and K. Verschueren Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells Mol. Cancer Res. 7 2009 1342 1353
15. Y. Kang, W. He, S. Tulley, G.P. Gupta, I. Serganova, C.-R. Chen, K. Manova-Todorova, R. Blasberg, W.L. Gerald, and J. Massagué Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway Proc. Natl. Acad. Sci. USA 102 2005 13909 13914
16. M. Petersen, E. Pardali, G. van der Horst, H. Cheung, C. van den Hoogen, G. van der Pluijm, and P. Dijke ten Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis Oncogene 29 2010 1351 1361
17. M. Oft, R.J. Akhurst, and A. Balmain Metastasis is driven by sequential elevation of H-ras and Smad2 levels Nat. Cell Biol. 2002 487 494
18. Y. Nisimoto, H.M. Jackson, H. Ogawa, T. Kawahara, and J.D. Lambeth Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain (2839512 ed.) Biochemistry 49 2010 2433 2442
19. L. Serrander, L. Cartier, K. Bedard, B. Banfi, B. Lardy, O. Plastre, A. Sienkiewicz, L. Fórró, W. Schlegel, and K.-H. Krause NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem. J. 406 2007 105 114
20. K.H. Zhang, H.Y. Tian, X. Gao, W.W. Lei, Y. Hu, D.M. Wang, X.C. Pan, M.L. Yu, G.J. Xu, F.K. Zhao, and J.G. Song Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition Cancer Res. 69 2009 5340 5348
21. H.E. Boudreau, B.W. Casterline, B. Rada, A. Korzeniowska, and T.L. Leto Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells Free Radic. Biol. Med. 53 2012 1489 1499
22. L. Hecker, R. Vittal, T. Jones, R. Jagirdar, T.R. Luckhardt, J.C. Horowitz, S. Pennathur, F.J. Martinez, and V.J. Thannickal NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury Nat. Med. 15 2009 1077 1081
23. E.K. Lee, W.-K. Jeon, M.Y. Chae, H.-Y. Hong, Y.S. Lee, J.H. Kim, J.Y. Kwon, B.-C. Kim, and S.H. Park Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells Biochem. Biophys. Res. Commun. 391 2010 1021 1027
24. K. Arsalane, C.M. Dubois, T. Muanza, R. Bégin, F. Boudreau, C. Asselin, and A.M. Cantin Transforming growth factor-beta1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase Am. J. Respir. Cell Mol. Biol. 17 1997 599 607
25. M. Peltoniemi, R. Kaarteenaho-Wiik, M. Säily, R. Sormunen, P. Pääkkö, A. Holmgren, Y. Soini, and V.L. Kinnula Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo Hum. Pathol. 35 2004 1000 1007
26. V.M. Felton, Z. Borok, and B.C. Willis N-Acetylcysteine inhibits alveolar epithelial-mesenchymal transition Am. J. Physiol. Lung Cell. Mol. Physiol. 297 2009 L805 L812
27. H.J. Forman, K.J.A. Davies, and F. Ursini How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo Free Radic. Biol. Med. 66 2014 24 35
28. S. Cannito, E. Novo, L.V. Di Bonzo, C. Busletta, S. Colombatto, and M. Parola Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease Antioxid. Redox Signal. 12 2010 1383 1430
29. M.R. Gorowiec, L.A. Borthwick, S.M. Parker, J.A. Kirby, G.C. Saretzki, and A.J. Fisher Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-β1-dependent mechanism Free Radic. Biol. Med. 52 2012 1024 1032
30. S.K. Meurer, B. Lahme, L. Tihaa, R. Weiskirchen, and A.M. Gressner N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug Biochem. Pharmacol. 70 2005 1026 1034
31. C. Michaeloudes, M.B. Sukkar, N.M. Khorasani, P.K. Bhavsar, and K.F. Chung TGF-β regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 300 2011 L295 L304
32. I. Cucoranu, R. Clempus, A. Dikalova, P.J. Phelan, S. Ariyan, S. Dikalov, and D. Sorescu NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts Circ. Res. 97 2005 900 907
33. A. Ono, M. Utsugi, K. Masubuchi, T. Ishizuka, T. Kawata, Y. Shimizu, T. Hisada, J. Hamuro, M. Mori, and K. Dobashi Glutathione redox regulates TGF-beta-induced fibrogenic effects through Smad3 activation FEBS Lett. 583 2009 357 362
34. N. Fatma, E. Kubo, Y. Takamura, K. Ishihara, C. Garcia, D.C. Beebe, and D.P. Singh Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling J. Biol. Chem. 284 2009 22758 22772
35. D.Y. Rhyu, Y. Yang, H. Ha, G.T. Lee, J.S. Song, S.-T. Uh, and H.B. Lee Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells J. Am. Soc. Nephrol. 16 2005 667 675
36. B.R. Stockwell, S.J. Haggarty, and S.L. Schreiber High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications Chem. Biol. 6 1999 71 83
37. V.G. Keshamouni, P. Jagtap, G. Michailidis, J.R. Strahler, R. Kuick, A.K. Reka, P. Papoulias, R. Krishnapuram, A. Srirangam, T.J. Standiford, P.C. Andrews, and G.S. Omenn Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition J. Proteome Res. 8 2009 35 47
38. M.A. Sartor, V. Mahavisno, V.G. Keshamouni, J. Cavalcoli, Z. Wright, A. Karnovsky, R. Kuick, H.V. Jagadish, B. Mirel, T. Weymouth, B. Athey, and G.S. Omenn ConceptGen: a gene set enrichment and gene set relation mapping tool Bioinformatics 26 2010 456 463
39. M.J. van der Werf Multivariate analysis of microarray data by principal component discriminant analysis: prioritizing relevant transcripts linked to the degradation of different carbohydrates in Pseudomonas putida S12 Microbiology 152 2006 257 272
40. Å.M. Wheelock, and C.E. Wheelock Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine Mol. Biosyst. 9 2013 2589 2596
41. 2: a quantitative comparison between continuous low-dose and one-time high-dose treatments Free Radic. Biol. Med. 60 2013 325 335
42. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212
43. P. Ranganathan, A. Agrawal, R. Bhushan, A. Chavalmane, R. Kalathur, T. Takahashi, and P. Kondaiah Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells BMC Genomics 8 2007 98
44. H. Kasai, J.T. Allen, R.M. Mason, T. Kamimura, and Z. Zhang TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) Respir. Res. 6 2005 56
45. J.H. Kim, Y.S. Jang, K.-S. Eom, Y.I. Hwang, H.R. Kang, S.H. Jang, C.H. Kim, Y.B. Park, M.G. Lee, I.G. Hyun, K.-S. Jung, and D.-G. Kim Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells J. Korean Med. Sci. 22 2007 898 904
46. H.N. Aguilar, B. Zielnik, C.N. Tracey, and B.F. Mitchell Quantification of rapid Myosin regulatory light chain phosphorylation using high-throughput in-cell Western assays: comparison to Western immunoblots PLoS One 5 2010 e9965
47. K.A. Janes, and M.B. Yaffe Data-driven modelling of signal-transduction networks Nat. Rev. Mol. Cell. Biol. 7 2006 820 828
48. V.G. Keshamouni, and W.P. Schiemann Epithelial-mesenchymal transition in tumor metastasis: a method to the madness Future Oncol. 5 2009 1109 1111
49. S.C. Lu Glutathione synthesis Biochim. Biophys. Acta 1830 2013 3143 3153
50. K.A. Brown, M.E. Aakre, A.E. Gorska, J.O. Price, S.E. Eltom, J.A. Pietenpol, and H.L. Moses Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro Breast Cancer Res. 6 2004 R215 R231
51. K. Yanagisawa, H. Osada, A. Masuda, M. Kondo, T. Saito, Y. Yatabe, K. Takagi, T. Takahashi, and T. Takahashi Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells Oncogene 17 1998 1743 1747
52. A.C. Poncelet, H.W. Schnaper, R. Tan, Y. Liu, and C.E. Runyan Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation J. Biol. Chem. 282 2007 15534 15540
53. H. Jardine, W. MacNee, K. Donaldson, and I. Rahman Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1 J. Biol. Chem. 277 2002 21158 21166
54. A.V. Bakin, N.V. Stourman, K.R. Sekhar, C. Rinehart, X. Yan, M.J. Meredith, C.L. Arteaga, and M.L. Freeman Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding phase II detoxifying proteins Free Radic. Biol. Med. 38 2005 375 387
55. J.Y. Chai, C. Modak, W. Mouazzen, R. Narvaez, and J. Pham Epithelial or mesenchymal: where to draw the line? Biosci. Trends 4 2010 130 142
56. 2O gradients across biomembranes FEBS Lett. 475 2000 121 126
57. M. Kemp, Y.-M. Go, and D.P. Jones Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology (2587159 ed.) Free Radic. Biol. Med. 44 2008 921 937
58. B. Kalyanaraman, V. Darley-Usmar, K.J.A. Davies, P.A. Dennery, H.J. Forman, M.B. Grisham, G.E. Mann, K. Moore, L.J. Roberts, and H. Ischiropoulos Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations Free Radic. Biol. Med. 52 2012 1 6
59. P. Wardman Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects Free Radic. Biol. Med. 43 2007 995 1022
60. M. Karlsson, T. Kurz, U.T. Brunk, S.E. Nilsson, and C.I. Frennesson What does the commonly used DCF test for oxidative stress really show? Biochem. J. 428 2010 183 190
61. A.C. Brown, V.F. Fiore, T.A. Sulchek, and T.H. Barker Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions J. Pathol. 229 2012 25 35
62. M. Tojo, Y. Hamashima, A. Hanyu, T. Kajimoto, M. Saitoh, K. Miyazono, M. Node, and T. Imamura The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta Cancer Sci. 96 2005 791 800
63. A.R. Aref, R.Y.-J. Huang, W. Yu, K.-N. Chua, W. Sun, T.-Y. Tu, J. Bai, W.-J. Sim, I.K. Zervantonakis, J.P. Thiery, and R.D. Kamm Screening therapeutic EMT blocking agents in a three-dimensional microenvironment Integr. Biol. 5 2013 381 389
64. W.Q. Li, H.Y. Qureshi, A. Liacini, F. Dehnade, and M. Zafarullah Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species Free Radic. Biol. Med. 37 2004 196 207
65. F.J. Lichtenberger, C. Montague, M. Hunter, G. Frambach, and C.B. Marsh NAC and DTT promote TGF-beta1 monomer formation: demonstration of competitive binding J. Inflamm. (Lond.) 3 2006 7
66. J. Vogt, R. Traynor, and G.P. Sapkota The specificities of small molecule inhibitors of the TGFß and BMP pathways Cell Signal. 23 2011 1831 1842
67. Y.E. Zhang Non-Smad pathways in TGF-beta signaling Cell Res. 19 2009 128 139
68. X.-F. Chen, H.-J. Zhang, H.-B. Wang, J. Zhu, W.-Y. Zhou, H. Zhang, M.-C. Zhao, J.-M. Su, W. Gao, L. Zhang, K. Fei, H.-T. Zhang, and H.-Y. Wang Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways Mol. Biol. Rep. 39 2011 3549 3556
69. L. Xie, B.K. Law, A.M. Chytil, K.A. Brown, M.E. Aakre, and H.L. Moses Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro Neoplasia 6 2004 603 610
70. J. Niu, Q. Mo, H. Wang, M. Li, J. Cui, Z. Li, and Z. Li Invasion inhibition by a MEK inhibitor correlates with the actin-based cytoskeleton in lung cancer A549 cells Biochem. Biophys. Res. Commun. 422 2012 80 84
71. C. Ramos, C. Becerril, M. Montaño, C. García-De-Alba, R. Ramírez, M. Checa, A. Pardo, and M. Selman FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway Am. J. Physiol. Lung Cell Mol. Physiol. 299 2010 L222 L231
72. Y.-C. Fong, S.-F. Hsu, C.-L. Wu, T.-M. Li, S.-T. Kao, F.-J. Tsai, W.-C. Chen, S.-C. Liu, C.-M. Wu, and C.-H. Tang Transforming growth factor-β1 increases cell migration and β1 integrin up-regulation in human lung cancer cells Lung Cancer 64 2009 13 21
73. E. Janda, K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grünert Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways J. Cell Biol. 156 2002 299 313
74. L. Zhang, W. Lei, X. Wang, Y. Tang, and J. Song Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-β1-induced epithelial-to-mesenchymal transition and cell migration FEBS Lett. 584 2010 4646 4654
75. D.J. Giard, S.A. Aaronson, G.J. Todaro, P. Arnstein, J.H. Kersey, H. Dosik, and W.P. Parks In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J. Natl. Cancer Inst. 51 1973 1417 1423
76. D.M. Valenzuela, and J. Groffen Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene Nucleic Acids Res. 14 1986 843 852
77. K. Horiguchi, T. Shirakihara, A. Nakano, T. Imamura, K. Miyazono, and M. Saitoh Role of Ras Signaling in the induction of Snail by transforming growth factor J. Biol. Chem. 284 2008 245 253
78. N. Tobar, J. Guerrero, P.C. Smith, J. Martínez, and R.O.S. NOX4-dependent production by stromal mammary cells modulates epithelial MCF-7 cell migration Br. J. Cancer 103 2010 1040 1047
79. D. Black, M.A. Bird, C.M. Samson, S. Lyman, P.A. Lange, L.W. Schrum, T. Qian, J.J. Lemasters, D.A. Brenner, R.A. Rippe, and K.E. Behrns Primary cirrhotic hepatocytes resist TGFβ-induced apoptosis through a ROS-dependent mechanism J. Hepatol. 40 2004 942 951
80. P. Sancho, and I. Fabregat Biochemical pharmacology Biochem. Pharmacol. Inc 81 2011 917 924
81. S.E. Eriksson, S. Prast-Nielsen, E. Flaberg, L. Szekely, and E.S.J. Arnér High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy Free Radic. Biol. Med. 47 2009 1661 1671
82. M.-H. Kweon, V.M. Adhami, J.-S. Lee, and H. Mukhtar Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate J. Biol. Chem. 281 2006 33761 33772
83. A. Singh, V. Misra, R.K. Thimmulappa, H. Lee, S. Ames, M.O. Hoque, J.G. Herman, S.B. Baylin, D. Sidransky, E. Gabrielson, M.V. Brock, and S. Biswal Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer Plos Med. 3 2006 e420